Page 48 - VI DERM BOOK COM (002)_FINAL

VI Peel Body Guidelines

C. DEFINING CLINICAL ENDPOINTS D. INTERVALS

The VI Peel Body’s blended formulation uniquely targets The body’s cell turnover is much slower than that of
the conditions of the body and are available in two sizes the face. With this physiological difference, patients
to best meet surface area needs. The full dose should be will experience a longer post-peel phase: Most patients
used unless terminal or undesirable endpoints are reached. experience peeling on the body beginning on day 5-7, with
Endpoints of application will vary from patient to patient peeling that lasts from 4-7 days. It’s recommended that
and body part to body part. To achieve optimal outcomes, you schedule a patient’s body peels every 4-8 weeks.
it is important to observe and respond to the skin response
during application. E. NUMBER OF TREATMENTS
Setting expectations early on is critical in assuring your
patients are satisfied with the process. When peeling the
Desirable Endpoints: Diffuse Erythema
(Mild to Moderate). body, it is important not to be overly aggressive, rather,
This indicates a thorough skin response and even product focus on a progressive peeling approach.
application. This can be more difficult to determine in It is typical to need 2-4 treatments for optimal outcomes
darker skin types. To compensate for the lack of visibility, on acne and hyperpigmentation.
allow 5+ Minute intervals between layers to insure you do
not over treat the skin. Creating a plan that safely and effectively meets your
patient’s expectations will assure their satisfaction
Terminal endpoints: Level I frost, severe erythema throughout the process.
that does not subside in 2-5 minutes,
edema/goosebumps.
A Level I frost is your terminal endpoint. It indicates
complete protein denaturation (coagulation). Further
application will increase a patient’s risk of delayed
healing, PIH, and potential scarring. Severe or Prominent
Erythema is a result of injury and skin response that is
heightened or could indicate reactive skin. To determine
the cause, allow 2-5 minutes for erythema to subside.
Edema or goosebumps can appear because of the AHAs
in the blend and would indicate complete epidermal
penetration.

Undesirable endpoints: Vesiculation,
Level II+ frost.
Vesiculation or blisters can occur if high volume of
peeling solution is placed in a single location or pooling
of solution occurs and is a result of the AHAs in the
blend. A Level II frost indicates deeper than expected
penetration into the dermis and, similar to what was
stated above, will result in a higher risk of delayed
healing, PIH, and scarring.

48